Table 2.
Univariate analysis of FGF1 and clinicopathologic parameters
| Characters | Survival time (mo) | 5-year survival rate | P* |
|---|---|---|---|
| Sex | |||
| Male | 53.1 | 41.4 | 0.252 |
| Female | 49.2 | 43.0 | |
| Age (years) | |||
| <60 | 54.2 | 43.6 | 0.324 |
| ≥60 | 50.6 | 41.0 | |
| Tumor diameter (cm) | |||
| ≤5 | 50.9 | 36.2 | 0.439 |
| >5 | 51.5 | 50.4 | |
| Tumor invasion | |||
| T1+T2 | 50.6 | 51.9 | 0.843 |
| T3+T4 | 54.7 | 41.2 | |
| Lymph node metastasis | |||
| No (N0) | 65.2 | 56.3 | 0.003 |
| Yes (N1/2/3) | 45.0 | 32.2 | |
| Distant metastasis | |||
| M0 | 58.8 | 47.9 | <0.001 |
| M1 | 16.5 | 22.4 | |
| TNM stage | |||
| I–II | 63.5 | 53.5 | 0.005 |
| III–IV | 38.5 | 32.2 | |
| Differentiation | |||
| Poor | 39.5 | 35.6 | 0.047 |
| Well + moderate | 60.1 | 50.7 | |
| FGF1 | |||
| Low | 59.1 | 47.5 | 0.021 |
| High | 38.3 | 41.0 | |
Note:
*
Log-rank test.
Abbreviations: FGF1, fibroblast growth factor 1; TNM, tumor, node, metastasis.